Correspondence 0001136261-23-000033 from Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc.
Date: Jan. 20, 2023 · CIK: 0001870144 · Accession: 0001136261-23-000033
AI Filing Summary & Sentiment
File numbers found in text: 333-268759
Show Raw Text
CORRESP 1 filename1.htm Cardio Diagnostics Holdings, Inc. 400 North Aberdeen Street, Suite 900 Chicago, IL 60642 January 20, 2023 VIA EDGAR Division of Corporation Finance Office of Life Sciences U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attn: Cindy Polynice Jason Drory Re: Cardio Diagnostics Holdings, Inc. Registration Statement on Form S-1 File No. 333-268759 Acceleration Request Requested Date: January 24, 2023 Requested Time: 4:30 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cardio Diagnostics Holdings, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-268759) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Shartsis Friese LLP, by calling Rupert Russell at (415) 425-5839. Please direct any questions or comments regarding this acceleration request to Mr. Russell at the above-telephone number. Thank you. [Signature page follows] Very truly yours, CARDIO DIAGNOSTICS HOLDINGS, INC. By: /s/ Elisa Luqman Elisa Luqman Chief Financial Officer cc: Meeshanthini Dogan, Ph.D. Chief Executive Officer P. Rupert Russell, Esq. Shartsis Friese LLP